ESG

A junior miner is fast-tracking gold and critical metals production in Québec by reviving a key mill. Is this a strategic supply chain win or just savvy promotion?

Acadia's new powder form of the only Rett syndrome drug offers families vital choice, easing daily care and showing the power of patient-led innovation.

A new nonprofit telehealth platform for men is launching, but its true innovation may lie in its ambitious blend of holistic care and community support.

A new AI-powered diagnostic test provides unprecedented clarity for millions at risk of esophageal cancer, challenging the old 'watch and wait' model.

As logistics giant Ryder plans a seamless CEO shift from Sanchez to insider John Diez, we analyze the strategy of continuity in a volatile market.

Creekstone Energy plans to add 2 gigawatts of nuclear power to its Utah Gigasite, a bold move to satisfy AI's insatiable energy appetite.

Bunker Hill Mining is pairing a strategic land grab with AI-driven exploration, a dual-pronged strategy aiming to revitalize a legendary American mining district.

With over 123 million displaced, refugee camps are now de facto cities. Temporary water solutions are fueling disease, making the case for permanent fixes.

The restaurant giant unveils a massive capital return plan, promising 100% of future free cash flow to investors while funding aggressive expansion in China.

atNorth's award-winning ICE03 facility isn't just a data center; it's a holistic model integrating green tech, circular economies, and community growth.

As Uxin prepares to report Q3 results, all eyes are on its ambitious superstore strategy and whether it can drive profitability in a complex market.

Genmab's $8 billion acquisition of Merus isn't just a deal; it's a bold strategy to own its destiny and dominate the future of oncology therapeutics.

SEALSQ appoints public-private partnership veteran Rolf Gobet to lead its new Geneva Quantum Center, a key move in a well-funded race against quantum threats.

A new startup is betting a premium AI desktop calendar can cure our smartphone addiction. But is another screen really the answer to too much screen time?

A South Korean firm has solved a hidden flaw in industrial magnets, promising a leap in efficiency for battery, recycling, and mining industries.

A new 'inspired by' fragrance brand is betting its vertically integrated model and aggressive pricing can break the industry’s century-old luxury spell.

Health Union's new platform for ATTR amyloidosis isn't just a website. It's a strategic blend of patient support and business innovation. Here's why.

Serina Therapeutics poaches a top chemist to expand its POZ platform, signaling a major push beyond Parkinson's into new, high-value drug markets.

Dialed Moods' new sea moss and shilajit gummies enter a booming market. But do the ancient ingredients and modern science justify the industry's latest rush?

Zoetis boosts its dividend by 6%, but what does this move signal about the company's financial health and the booming global animal care market?